-
Články
- Časopisy
- Kurzy
- Témy
- Kongresy
- Videa
- Podcasty
Appendix diagnostica – Familial hypercholesterolemia diagnostic criteria
Published in the journal: Vnitř Lék 2017; 63(1): 49
Category:
Simon Broome system
Definite familial hypercholesterolemia (FH) is defined as follows:
a) cholesterol levels > 6.7 in children under 16 years of age and > 7.5 in adults; or LDL-C levels > 4.9 in adults
and
b) tendinous xanthomas in a patient or a first-/second-degree relative.
Possible familial hypercholesterolemia is defined as follows:
a) cholesterol levels > 6.7 in children under 16 years of age and > 7.5 in adults; or LDL-C levels > 4.9 in adults
and one of the following criteria:
b) family history of myocardial infarction prior to 50 years of age in second-degree relatives, or prior to 60 years in first-degree relatives
c) family history of elevated cholesterol > 7.5 in first-/second-degree relatives.
MedPed criteria used in the United States
Tab. 1. Total cholesterol cutpoints (in mmol/l) used in FH diagnosis in MedPed
Diagnosis: FH is diagnosed if total cholesterol levels exceed the Cut Point Dutch Lipid Clinic Network criteria for FH
Tab. 2. Dutch criteria points
CAD – coronary artery disease M – male F – female LDL-C – low density cholesterol The Dutch criteria are then interpreted as follows: For a definite diagnosis of FH, the subject must have more than 8 points; a probable diagnosis of FH requires 6–8 points; and a possible diagnosis of FH is indicated by 3–5 points. Patients who score 0–2 points most likely do not have FH.
Štítky
Diabetológia Endokrinológia Interné lekárstvo
Článok vyšiel v časopiseVnitřní lékařství
Najčítanejšie tento týždeň
2017 Číslo 1- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Rizikové období v léčbě růstovým hormonem: přechod mladých pacientů k lékařům pro dospělé
- Intermitentní hladovění v prevenci a léčbě chorob
- Statinová intolerance
- Monoklonální protilátky v léčbě hyperlipidemií
-
Všetky články tohto čísla
- Familiární hypercholesterolermie: z Čech a Moravy do celého světa – editorial
- Význam hodnocení ventilační efektivity VE/VCO2 slope u pacientů se srdečním selháním – editorial
- Progresivní multifokální leukoencefalopatie – editorial
- ScreenPro FH – Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology
- Closure of the left atrial appendage by means of the AtriClip System
- Treatment of HCV genotype 2 infection
- ScreenPro FH – Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design
- Appendix diagnostica – Familial hypercholesterolemia diagnostic criteria
- Predatory journals: how their publishers operate and how to avoid them
- A contribution to the differential diagnostics of sclerosing cholangitides
- The importance of evaluating the effectiveness of the ventilation VE/VCO2 slope in patients with heart failure
- Rituximab-associated progressive multifocal leukoencephalopathy
- 2nd Prague European Days of Internal Medicine
- Spomienka na profesora MUDr. Karla Horkého, DrSc., FACP (Hon), FEFIM
- Z odborné literatury
- Z odborné literatury
- Vnitřní lékařství
- Archív čísel
- Aktuálne číslo
- Iba online
- Informácie o časopise
Najčítanejšie v tomto čísle- Closure of the left atrial appendage by means of the AtriClip System
- The importance of evaluating the effectiveness of the ventilation VE/VCO2 slope in patients with heart failure
- Rituximab-associated progressive multifocal leukoencephalopathy
- A contribution to the differential diagnostics of sclerosing cholangitides
Prihlásenie#ADS_BOTTOM_SCRIPTS#Zabudnuté hesloZadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
- Časopisy